Rhythm Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBoston, MA
US patents11
SAM.gov UEIG9KGU2YDQNU4
CAGE code70V50
Incorporated inMA
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
11 US patents granted 2017–2025, 8 of them in the five years to SEP 2025.
Pharmaceuticals 11
- Pharmaceutical compositionsUS 12,285,460 · granted APR 29, 2025
- Method of treating melanocortin-4 receptor pathway-associated disordersUS 12,263,202 · granted APR 1, 2025
- Peptide compositionsUS 12,077,612 · granted SEP 3, 2024
- Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersUS 11,702,448 · granted JUL 18, 2023
- Pharmaceutical compositionsUS 11,129,869 · granted SEP 28, 2021
Newest 5 shown · Granted to Rhythm Pharmaceuticals, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | Boston | MA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.